Global Hypertension and Heart Failure Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18653596 | Publishing Date : 24-Jun-2021 | No. of pages : 113
Detailed TOC of Global Hypertension and Heart Failure Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Hypertension and Heart Failure Drugs1.1 Hypertension and Heart Failure Drugs Market Overview
1.1.1 Hypertension and Heart Failure Drugs Product Scope
1.1.2 Hypertension and Heart Failure Drugs Market Status and Outlook
1.2 Global Hypertension and Heart Failure Drugs Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Hypertension and Heart Failure Drugs Market Size by Region (2016-2027)
1.4 Global Hypertension and Heart Failure Drugs Historic Market Size by Region (2016-2021)
1.5 Global Hypertension and Heart Failure Drugs Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Hypertension and Heart Failure Drugs Market Size (2016-2027)
1.6.1 North America Hypertension and Heart Failure Drugs Market Size (2016-2027)
1.6.2 Europe Hypertension and Heart Failure Drugs Market Size (2016-2027)
1.6.3 Asia-Pacific Hypertension and Heart Failure Drugs Market Size (2016-2027)
1.6.4 Latin America Hypertension and Heart Failure Drugs Market Size (2016-2027)
1.6.5 Middle East & Africa Hypertension and Heart Failure Drugs Market Size (2016-2027)
2 Hypertension and Heart Failure Drugs Market Overview by Type
2.1 Global Hypertension and Heart Failure Drugs Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Hypertension and Heart Failure Drugs Historic Market Size by Type (2016-2021)
2.3 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2022-2027)
2.4 Diuretics
2.5 Beta Blockers
2.6 Ace Inhibitors
2.7 Alpha Blockers
2.8 Others
3 Hypertension and Heart Failure Drugs Market Overview by Application
3.1 Global Hypertension and Heart Failure Drugs Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Hypertension and Heart Failure Drugs Historic Market Size by Application (2016-2021)
3.3 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2022-2027)
3.4 Men
3.5 Women
4 Hypertension and Heart Failure Drugs Competition Analysis by Players
4.1 Global Hypertension and Heart Failure Drugs Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypertension and Heart Failure Drugs as of 2020)
4.3 Date of Key Players Enter into Hypertension and Heart Failure Drugs Market
4.4 Global Top Players Hypertension and Heart Failure Drugs Headquarters and Area Served
4.5 Key Players Hypertension and Heart Failure Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Hypertension and Heart Failure Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Menarini Group
5.1.1 Menarini Group Profile
5.1.2 Menarini Group Main Business
5.1.3 Menarini Group Hypertension and Heart Failure Drugs Products, Services and Solutions
5.1.4 Menarini Group Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.1.5 Menarini Group Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Hypertension and Heart Failure Drugs Products, Services and Solutions
5.2.4 Johnson & Johnson Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.2.5 Johnson & Johnson Recent Developments
5.3 Lupin
5.5.1 Lupin Profile
5.3.2 Lupin Main Business
5.3.3 Lupin Hypertension and Heart Failure Drugs Products, Services and Solutions
5.3.4 Lupin Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.3.5 Boehringer Ingelheim Recent Developments
5.4 Boehringer Ingelheim
5.4.1 Boehringer Ingelheim Profile
5.4.2 Boehringer Ingelheim Main Business
5.4.3 Boehringer Ingelheim Hypertension and Heart Failure Drugs Products, Services and Solutions
5.4.4 Boehringer Ingelheim Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.4.5 Boehringer Ingelheim Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Hypertension and Heart Failure Drugs Products, Services and Solutions
5.5.4 Novartis Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.5.5 Novartis Recent Developments
5.6 Merck & Co
5.6.1 Merck & Co Profile
5.6.2 Merck & Co Main Business
5.6.3 Merck & Co Hypertension and Heart Failure Drugs Products, Services and Solutions
5.6.4 Merck & Co Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.6.5 Merck & Co Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Hypertension and Heart Failure Drugs Products, Services and Solutions
5.7.4 AstraZeneca Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.7.5 AstraZeneca Recent Developments
5.8 Pfizer, Inc
5.8.1 Pfizer, Inc Profile
5.8.2 Pfizer, Inc Main Business
5.8.3 Pfizer, Inc Hypertension and Heart Failure Drugs Products, Services and Solutions
5.8.4 Pfizer, Inc Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.8.5 Pfizer, Inc Recent Developments
5.9 Sanofi SA
5.9.1 Sanofi SA Profile
5.9.2 Sanofi SA Main Business
5.9.3 Sanofi SA Hypertension and Heart Failure Drugs Products, Services and Solutions
5.9.4 Sanofi SA Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.9.5 Sanofi SA Recent Developments
5.10 Dr. Reddy's Laboratories
5.10.1 Dr. Reddy's Laboratories Profile
5.10.2 Dr. Reddy's Laboratories Main Business
5.10.3 Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Products, Services and Solutions
5.10.4 Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.10.5 Dr. Reddy's Laboratories Recent Developments
5.11 Daiichi Sankyo Company Limited
5.11.1 Daiichi Sankyo Company Limited Profile
5.11.2 Daiichi Sankyo Company Limited Main Business
5.11.3 Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Products, Services and Solutions
5.11.4 Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Revenue (US$ Million) & (2016-2021)
5.11.5 Daiichi Sankyo Company Limited Recent Developments
6 North America
6.1 North America Hypertension and Heart Failure Drugs Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Hypertension and Heart Failure Drugs Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hypertension and Heart Failure Drugs Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hypertension and Heart Failure Drugs Market Dynamics
11.1 Hypertension and Heart Failure Drugs Industry Trends
11.2 Hypertension and Heart Failure Drugs Market Drivers
11.3 Hypertension and Heart Failure Drugs Market Challenges
11.4 Hypertension and Heart Failure Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Hypertension and Heart Failure Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Hypertension and Heart Failure Drugs Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Hypertension and Heart Failure Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Hypertension and Heart Failure Drugs Market Size Share by Region (2016-2021)
Table 4. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Hypertension and Heart Failure Drugs Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Hypertension and Heart Failure Drugs Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Hypertension and Heart Failure Drugs Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2022-2027)
Table 11. Global Hypertension and Heart Failure Drugs Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Hypertension and Heart Failure Drugs Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Hypertension and Heart Failure Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Hypertension and Heart Failure Drugs Revenue Market Share by Application (2022-2027)
Table 16. Global Hypertension and Heart Failure Drugs Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Hypertension and Heart Failure Drugs Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypertension and Heart Failure Drugs as of 2020)
Table 19. Date of Key Manufacturers Enter into Hypertension and Heart Failure Drugs Market
Table 20. Global Hypertension and Heart Failure Drugs Top Players Headquarters and Area Served
Table 21. Hypertension and Heart Failure Drugs Product Solution and Service
Table 22. Global Hypertension and Heart Failure Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Menarini Group Basic Information List
Table 25. Menarini Group Description and Business Overview
Table 26. Menarini Group Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 27. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Menarini Group (2016-2021)
Table 28. Menarini Group Recent Developments
Table 29. Johnson & Johnson Basic Information List
Table 30. Johnson & Johnson Description and Business Overview
Table 31. Johnson & Johnson Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 32. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Johnson & Johnson (2016-2021)
Table 33. Johnson & Johnson Recent Developments
Table 34. Lupin Basic Information List
Table 35. Lupin Description and Business Overview
Table 36. Lupin Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 37. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Lupin (2016-2021)
Table 38. Lupin Recent Developments
Table 39. Boehringer Ingelheim Basic Information List
Table 40. Boehringer Ingelheim Description and Business Overview
Table 41. Boehringer Ingelheim Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 42. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Boehringer Ingelheim (2016-2021)
Table 43. Boehringer Ingelheim Recent Developments
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Novartis (2016-2021)
Table 48. Novartis Recent Developments
Table 49. Merck & Co Basic Information List
Table 50. Merck & Co Description and Business Overview
Table 51. Merck & Co Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Merck & Co (2016-2021)
Table 53. Merck & Co Recent Developments
Table 54. AstraZeneca Basic Information List
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of AstraZeneca (2016-2021)
Table 58. AstraZeneca Recent Developments
Table 59. Pfizer, Inc Basic Information List
Table 60. Pfizer, Inc Description and Business Overview
Table 61. Pfizer, Inc Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Pfizer, Inc (2016-2021)
Table 63. Pfizer, Inc Recent Developments
Table 64. Sanofi SA Basic Information List
Table 65. Sanofi SA Description and Business Overview
Table 66. Sanofi SA Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Sanofi SA (2016-2021)
Table 68. Sanofi SA Recent Developments
Table 69. Dr. Reddy's Laboratories Basic Information List
Table 70. Dr. Reddy's Laboratories Description and Business Overview
Table 71. Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Dr. Reddy's Laboratories (2016-2021)
Table 73. Dr. Reddy's Laboratories Recent Developments
Table 74. Daiichi Sankyo Company Limited Basic Information List
Table 75. Daiichi Sankyo Company Limited Description and Business Overview
Table 76. Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Hypertension and Heart Failure Drugs Business of Daiichi Sankyo Company Limited (2016-2021)
Table 78. Daiichi Sankyo Company Limited Recent Developments
Table 79. North America Hypertension and Heart Failure Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 80. North America Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 81. Europe Hypertension and Heart Failure Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 82. Europe Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 83. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 84. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 85. Asia-Pacific Hypertension and Heart Failure Drugs Market Share by Region (2016-2021)
Table 86. Asia-Pacific Hypertension and Heart Failure Drugs Market Share by Region (2022-2027)
Table 87. Latin America Hypertension and Heart Failure Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 88. Latin America Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 89. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Players (2016-2021) & (US$ Million)
Table 90. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 91. Hypertension and Heart Failure Drugs Market Trends
Table 92. Hypertension and Heart Failure Drugs Market Drivers
Table 93. Hypertension and Heart Failure Drugs Market Challenges
Table 94. Hypertension and Heart Failure Drugs Market Restraints
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypertension and Heart Failure Drugs Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Hypertension and Heart Failure Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Hypertension and Heart Failure Drugs Market Share by Regions: 2021 VS 2027
Figure 4. Global Hypertension and Heart Failure Drugs Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Hypertension and Heart Failure Drugs Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Hypertension and Heart Failure Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Hypertension and Heart Failure Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Hypertension and Heart Failure Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Hypertension and Heart Failure Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Hypertension and Heart Failure Drugs Market Size Share by Type in 2021 & 2027
Figure 11. Diuretics Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Beta Blockers Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Ace Inhibitors Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Alpha Blockers Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Others Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Global Hypertension and Heart Failure Drugs Market Size Share by Application in 2021 & 2027
Figure 17. Men Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Women Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Hypertension and Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Top 5 and Top 10 Players Hypertension and Heart Failure Drugs Market Share in 2020
Figure 21. North America Hypertension and Heart Failure Drugs Market Share by Country (2016-2027)
Figure 22. United States Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 23. Canada Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 24. Germany Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 25. France Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 26. U.K. Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 27. Italy Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 28. Russia Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 29. Nordic Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 30. Rest of Europe Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 31. Asia-Pacific Hypertension and Heart Failure Drugs Market Share by Region (2016-2027)
Figure 32. China Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 33. Japan Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 34. South Korea Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 35. Southeast Asia Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 36. India Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 37. Australia Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 38. Rest of Asia-Pacific Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 39. Latin America Hypertension and Heart Failure Drugs Market Share by Country (2016-2027)
Figure 40. Mexico Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 41. Brazil Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 42. Rest of Latin America Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 43. Middle East & Africa Hypertension and Heart Failure Drugs Market Share by Country (2016-2027)
Figure 44. Turkey Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 45. Saudi Arabia Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 46. UAE Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 47. Rest of Middle East & Africa Hypertension and Heart Failure Drugs Market Size (2016-2027) & (US$ Million)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Keyplayers in Global Hypertension and Heart Failure Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Menarini GroupJohnson & Johnson
Lupin
Boehringer Ingelheim
Novartis
Merck & Co
AstraZeneca
Pfizer, Inc
Sanofi SA
Dr. Reddy's Laboratories
Daiichi Sankyo Company Limited